Epigenómica y Política de Asistencia Sanitaria: Retos y Oportunidades 1-3 de diciembre, Instituto Europeo de Oncología, Milán, Italia

EPIGENomics and Health Care policy: Challenges and Opportunities

EVENTOS

Próximos eventos internacionales de enfermedades raras Epigenómica y Política de Asistencia Sanitaria: Retos y Oportunidades 1-3 de diciembre, Instituto Europeo de Oncología, Milán, Italia EPIGENomics and Health Care Policy: Challenges and Opportunities   December 1-3, 2014 IEO, via Adamello 16, Milan, Italy INTRODUCTION The rise of epigenomics has been exponential over the last decade, in terms of scientific breakthroughs and technological advances as well as in the public salience of its discourse. Its impact is particularly promising in biomedicine, where epigenomic signatures are expected to bridge the gap between human genetic variation and clinical phenotypes, with possibly paradigm-shifting implications for disease classification, prognostic stratifications and therapeutic regimens. Developments are no less momentous when it comes to preventive, occupational and environmental studies, where the possibility to digitize exposures and standardize them in terms of epigenomic readouts is expected to have far reaching impacts. Unsurprisingly, the investigation of the ethical, legal and social issues (ELSI) of epigenomics has also started to advance, beginning to highlight commonalities and differences vis à vis the previous two decades of genome-centered focus. The time is thus ripe to assess the impact of these advances in the context of health care delivery and policy, for whose analysis this meeting will provide a timely first opportunity at the international level. The aim is to bring together leading epigenomics scientists with policy makers, clinician representatives, patient organizations and ELSI scholars in order to define the critical challenges and opportunities ahead of us in the translation of epigenomic science into healthcare practice, both at the national and transnational levels.   ORGANIZERS Giuseppe Testa - European Institute of Oncology, Milan Giuseppe Macino - Sapienza University of Rome, Rome Luca Chiapperino - European Institute of Oncology, Milan Maria Damjanovicova - European Institute of Oncology, Milan   SPEAKERS Geneviève Almouzni - Institut Curie, Paris Bruno Amati - Italian Institute of Technology, Milan Ruth Chadwick - Cardiff University, Cardiff Davide Gabellini - San Raffaele Scientific Institute, Milan Alex Gutteridge - Neusentis Cambridge Nils Hoppe - University of Hannover, Hannover Yann Joly - McGill University, Montreal Hannah Landecker - University of California, Los Angeles Giuseppe Macino - Sapienza University of Rome, Rome Maurizio Meloni - Princeton and University of Sheffield Karin Michels - Harvard University, Boston Saverio Minucci - IEO, Milan Gioacchino Natoli - IEO, Milan Udo Oppermann - University of Oxford, Oxford Massimiliano Pagani - Foundation INGM, Milan Pier Giuseppe Pelicci - European Institute of Oncology, Milan Barbara Prainsack - King's College, London Silvia Stringhini - Lausanne University Hospital, Lausanne Henk Stunnenberg - University of Nijmegen, Nijmegen Giuseppe Testa - European Institute of Oncology, Milan Jörn Walter - Saarland University, Saarbrücken   The number of participants is limited to 120